Spero Therapeutics SPRO
NASDAQ SPRO
$1.14 -0.03 (-2.74%)
As of: Oct 22, 2026 · 2:25 PM EDT

Spero Therapeutics (SPRO) Ending Cash Balance (2016 - 2026)

Updated

Analysis

Spero Therapeutics (SPRO) Ending Cash Balance (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,171.69 Bn 1,140.28 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 649.22 Bn 569.08 Bn 17.30 Bn 16.91 Bn
3 AbbVie 504.17 Bn 477.29 Bn 12.70 Bn 6.57 Bn
4 Merck 366.35 Bn 320.73 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 303.54 Bn 267.53 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 269.49 Bn 243.18 Bn 12.86 Bn 4.88 Bn
7 Amgen 242.61 Bn 198.01 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 195.09 Bn 169.29 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.48 Bn 119.12 Bn 10.94 Bn 1.03 Bn
10 Spero Therapeutics 65.97 Mn -129.82 Mn - 50.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50.77 Mn
Mar 31, 2026 56.13 Mn
Dec 31, 2025 40.27 Mn
Sep 30, 2025 48.62 Mn
Jun 30, 2025 31.19 Mn
Mar 31, 2025 48.89 Mn
Dec 31, 2024 52.89 Mn
Sep 30, 2024 76.29 Mn
Jun 30, 2024 63.53 Mn
Mar 31, 2024 82.27 Mn
Dec 31, 2023 76.33 Mn
Sep 30, 2023 93.83 Mn
Jun 30, 2023 77.69 Mn
Mar 31, 2023 96.25 Mn
Dec 31, 2022 109.11 Mn
Sep 30, 2022 50.45 Mn
Jun 30, 2022 45.40 Mn
Mar 31, 2022 72.11 Mn
Dec 31, 2021 112.58 Mn
Sep 30, 2021 112.86 Mn
API Access

Spero Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=SPRO&period=max&api_key=YOUR_API_KEY